Wang F, He MM, Xiao J, Zhang YQ, et al. A randomized, open-label, multicenter, phase 3 study of high-dose vitamin C plus FOLFOX +/- bevacizumab versus FOLFOX +/- bevacizumab in unresectable untreated metastatic colorectal cancer. Clin Cancer Res 2022 Aug 5. pii: 707466. doi: 10.1158/1078-0432.CCR-22-0655.
PMID: 35929990